Jay Schmelter

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA.

Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO.

InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX.

Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX.

Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO.

Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO.

Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC.

Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO.

Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC.

InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA.

Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC.

Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC.

Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX.

Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.

Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX.

RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri.